Australia Implements Stricter Regulations on E-Cigarettes to Curb Youth Usage

Regulations by 2FIRSTS.ai
Jan.04.2024
Australia Implements Stricter Regulations on E-Cigarettes to Curb Youth Usage
Australian Federal Government strengthens crackdown on e-cigarettes among primary school students, banning disposable e-cigarettes effective January 1, 2024.

According to a report from the Daily Freeman on January 4th, the Australian federal government has intensified its crackdown on e-cigarettes as their popularity increases among elementary school students. The new regulations will officially come into effect on January 1st, 2024. This decision has garnered strong support from Charles Gough, the Executive Principal of Debo Academy.

 

The key provisions of the new regulation include a ban on disposable e-cigarettes, aiming to curb the alarming trend among students. Principal Gao Qi, who oversees implementation, describes this as a "highly positive measure" that will make it more difficult for young people to access e-cigarettes. He emphasizes that this ban, along with enforcement measures and ongoing education and support provided by schools, will have a significant positive impact on addressing the serious threat posed to student health by e-cigarettes.

 

According to a federal government investigation, disposable e-cigarettes have become the preferred choice for 80% of school students. Among teenagers aged 16 to 24, 16.5% admit to being regular e-cigarette users, a significant increase from the previous 11.1%. Shockingly, even elementary school students have been found vaping on school premises.

 

Federal Health Minister Mark Butler said, "The ban on disposable e-cigarettes is only the first step in the government's e-cigarette reform."

 

Starting from March 1, 2024, the rechargeable e-cigarettes will also be prohibited, and there will be further regulations on flavors, nicotine concentration levels, and packaging.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Argentina's Neuquén province reiterates e-cigarette ban, covering import, distribution, and marketing
Argentina's Neuquén province reiterates e-cigarette ban, covering import, distribution, and marketing
The Consumer Protection Agency of Neuquén Province, Argentina, reiterated on September 24 that the ban on the import, distribution, marketing and advertising of e-cigarettes, similar devices and related accessories is fully effective. The restriction also covers "heated tobacco products" based on Resolution No. 565/2023 of the Ministry of Health and Regulation No. 3226/2011 of ANMAT.
Sep.25 by 2FIRSTS.ai
JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL's regulatory journey from Marketing Denial Order to approval showcases FDA's evolving approach to e-cigarette oversight.
Nov.03 by 2FIRSTS.ai
2Firsts Monitor | FOGER website flags customs & tariff delays; some products out of stock
2Firsts Monitor | FOGER website flags customs & tariff delays; some products out of stock
2Firsts observed on FOGER’s online retail site “FOGER VAPES” that the platform indicates restocking delays due to customs and tariff factors. Several items show limited availability or “sold out” status, with a restock alert feature offered. A previous article on the site also referenced potential tariff changes that may affect pricing.
Nov.05
69% of Russians Support Full Ban on E-Cigarette Sales, SuperJob Survey Shows
69% of Russians Support Full Ban on E-Cigarette Sales, SuperJob Survey Shows
According to Gazeta.Ru, a SuperJob poll found that 69% of Russians support President Vladimir Putin’s decision to fully ban vape sales in Russia. Only 7% oppose the ban, while 15% said they are indifferent and 9% were undecided.
Nov.10 by 2FIRSTS.ai
Research Brief | Altria Study Finds Limited Impact of Massachusetts Flavor Ban on Adult Smoking Rates
Research Brief | Altria Study Finds Limited Impact of Massachusetts Flavor Ban on Adult Smoking Rates
A replication study by Altria scientists published in AJPM Focus evaluated the effect of Massachusetts’ comprehensive flavored‐tobacco ban,the study found that while Massachusetts’ smoking rate continued to decline after the ban, it did not fall faster than in comparison states without flavor bans. Overall, Massachusetts fell from about 14.1% to 10.7%, while comparison states fell from 18.5% to 14.8%. The authors conclude that, for adult smoking prevalence, no additional net decline attributable
Sep.24 by 2FIRSTS.ai